- Home
- EZGO vs TCBP Comparison
EZGO vs TCBP Comparison
Compare EZGO & TCBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EZGO
- TCBP
- Stock Information
- Founded
- EZGO 2014
- TCBP 2013
- Country
- EZGO China
- TCBP United Kingdom
- Employees
- EZGO N/A
- TCBP N/A
- Industry
- EZGO Motor Vehicles
- TCBP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- EZGO Consumer Discretionary
- TCBP Health Care
- Exchange
- EZGO Nasdaq
- TCBP Nasdaq
- Market Cap
- EZGO 2.6M
- TCBP 3.0M
- IPO Year
- EZGO 2021
- TCBP 2022
- Fundamental
- Price
- EZGO $0.92
- TCBP $0.68
- Analyst Decision
- EZGO
- TCBP
- Analyst Count
- EZGO 0
- TCBP 0
- Target Price
- EZGO N/A
- TCBP N/A
- AVG Volume (30 Days)
- EZGO 73.0K
- TCBP 3.0M
- Earning Date
- EZGO 09-09-2024
- TCBP 11-29-2024
- Dividend Yield
- EZGO N/A
- TCBP N/A
- EPS Growth
- EZGO N/A
- TCBP N/A
- EPS
- EZGO N/A
- TCBP N/A
- Revenue
- EZGO $19,334,254.00
- TCBP N/A
- Revenue This Year
- EZGO N/A
- TCBP N/A
- Revenue Next Year
- EZGO N/A
- TCBP N/A
- P/E Ratio
- EZGO N/A
- TCBP N/A
- Revenue Growth
- EZGO 14.03
- TCBP N/A
- 52 Week Low
- EZGO $0.85
- TCBP $0.56
- 52 Week High
- EZGO $5.04
- TCBP $138.00
- Technical
- Relative Strength Index (RSI)
- EZGO 33.32
- TCBP 23.01
- Support Level
- EZGO $0.95
- TCBP $1.05
- Resistance Level
- EZGO $1.12
- TCBP $1.25
- Average True Range (ATR)
- EZGO 0.08
- TCBP 0.22
- MACD
- EZGO -0.01
- TCBP 0.06
- Stochastic Oscillator
- EZGO 12.29
- TCBP 10.36
About EZGO EZGO Technologies Ltd.
EZGO Technologies Ltd is engaged in the sale of e-bicycles and battery and e-bicycle rentals, complemented by the sale of battery packs, battery cell trading and charging pile business. Its product categories include e-bicycle, Intelligent unmanned patrol car, e-motorcycle and e-moped and urban style e-tricycle. Its segments include the Battery cells and packs, electronic control system and intelligent robot segment. and the E-bicycle sales segment. The company generates maximum revenue from the Battery cells and packs segment.
About TCBP TC BioPharm (Holdings) plc
TC BioPharm (Holdings) PLC is a clinical-stage biopharmaceutical company focused on developing novel immunotherapy products that are based on its proprietary allogeneic gamma delta T (abbreviated as GD-T) cell platform. Harnessing the innate ability of GD-Ts has enabled the company to develop a range of clinical-stage cell therapies designed to combat cancer and viral infection.